These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 33130104

  • 1. Evaluating Responses to Gluten Challenge: A Randomized, Double-Blind, 2-Dose Gluten Challenge Trial.
    Leonard MM, Silvester JA, Leffler D, Fasano A, Kelly CP, Lewis SK, Goldsmith JD, Greenblatt E, Kwok WW, McAuliffe WJ, Galinsky K, Siegelman J, Chow IT, Wagner JA, Sapone A, Smithson G.
    Gastroenterology; 2021 Feb; 160(3):720-733.e8. PubMed ID: 33130104
    [Abstract] [Full Text] [Related]

  • 2. HLA-DQ:gluten tetramer test in blood gives better detection of coeliac patients than biopsy after 14-day gluten challenge.
    Sarna VK, Skodje GI, Reims HM, Risnes LF, Dahal-Koirala S, Sollid LM, Lundin KEA.
    Gut; 2018 Sep; 67(9):1606-1613. PubMed ID: 28779027
    [Abstract] [Full Text] [Related]

  • 3. HLA-DQ-Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption.
    Sarna VK, Lundin KEA, Mørkrid L, Qiao SW, Sollid LM, Christophersen A.
    Gastroenterology; 2018 Mar; 154(4):886-896.e6. PubMed ID: 29146521
    [Abstract] [Full Text] [Related]

  • 4. A bispecific antibody targeting HLA-DQ2.5-gluten peptides potently blocks gluten-specific T cells induced by gluten ingestion in patients with celiac disease.
    Hardy MY, Henneken LM, Russell AK, Okura Y, Mizoroki A, Ozono Y, Kobayashi S, Murakami Y, Tye-Din JA.
    Clin Immunol; 2024 Jul; 264():110259. PubMed ID: 38768856
    [Abstract] [Full Text] [Related]

  • 5. Ex-vivo whole blood secretion of interferon (IFN)-γ and IFN-γ-inducible protein-10 measured by enzyme-linked immunosorbent assay are as sensitive as IFN-γ enzyme-linked immunospot for the detection of gluten-reactive T cells in human leucocyte antigen (HLA)-DQ2·5(+) -associated coeliac disease.
    Ontiveros N, Tye-Din JA, Hardy MY, Anderson RP.
    Clin Exp Immunol; 2014 Feb; 175(2):305-15. PubMed ID: 24192268
    [Abstract] [Full Text] [Related]

  • 6. Gluten-Free Diet Induces Rapid Changes in Phenotype and Survival Properties of Gluten-Specific T Cells in Celiac Disease.
    Risnes LF, Reims HM, Doyle RM, Qiao SW, Sollid LM, Lundin KEA, Christophersen A.
    Gastroenterology; 2024 Jul; 167(2):250-263. PubMed ID: 38552723
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.
    Daveson AJM, Ee HC, Andrews JM, King T, Goldstein KE, Dzuris JL, MacDougall JA, Williams LJ, Treohan A, Cooreman MP, Anderson RP.
    EBioMedicine; 2017 Dec; 26():78-90. PubMed ID: 29191561
    [Abstract] [Full Text] [Related]

  • 9. A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease.
    Hardy MY, Goel G, Russell AK, Chen Yi Mei SLG, Brown GJE, Wang S, Szymczak E, Zhang R, Goldstein KE, Neff KM, Williams LJ, Truitt KE, Dzuris JL, Tye-Din JA, Anderson RP.
    Front Immunol; 2021 Dec; 12():661622. PubMed ID: 34093551
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pathogenic T Cells in Celiac Disease Change Phenotype on Gluten Challenge: Implications for T-Cell-Directed Therapies.
    Christophersen A, Zühlke S, Lund EG, Snir O, Dahal-Koirala S, Risnes LF, Jahnsen J, Lundin KEA, Sollid LM.
    Adv Sci (Weinh); 2021 Nov; 8(21):e2102778. PubMed ID: 34495570
    [Abstract] [Full Text] [Related]

  • 13. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
    Bodd M, Kim CY, Lundin KE, Sollid LM.
    Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
    [Abstract] [Full Text] [Related]

  • 14. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
    Høydahl LS, Richter L, Frick R, Snir O, Gunnarsen KS, Landsverk OJB, Iversen R, Jeliazkov JR, Gray JJ, Bergseng E, Foss S, Qiao SW, Lundin KEA, Jahnsen J, Jahnsen FL, Sandlie I, Sollid LM, Løset GÅ.
    Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
    [Abstract] [Full Text] [Related]

  • 15. TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study.
    Kelly CP, Murray JA, Leffler DA, Getts DR, Bledsoe AC, Smithson G, First MR, Morris A, Boyne M, Elhofy A, Wu TT, Podojil JR, Miller SD, TAK-101 Study Group.
    Gastroenterology; 2021 Jul; 161(1):66-80.e8. PubMed ID: 33722583
    [Abstract] [Full Text] [Related]

  • 16. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.
    Lähdeaho ML, Kaukinen K, Laurila K, Vuotikka P, Koivurova OP, Kärjä-Lahdensuu T, Marcantonio A, Adelman DC, Mäki M.
    Gastroenterology; 2014 Jun; 146(7):1649-58. PubMed ID: 24583059
    [Abstract] [Full Text] [Related]

  • 17. Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients.
    Ráki M, Fallang LE, Brottveit M, Bergseng E, Quarsten H, Lundin KE, Sollid LM.
    Proc Natl Acad Sci U S A; 2007 Feb 20; 104(8):2831-6. PubMed ID: 17307878
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study.
    Lähdeaho ML, Scheinin M, Vuotikka P, Taavela J, Popp A, Laukkarinen J, Koffert J, Koivurova OP, Pesu M, Kivelä L, Lovró Z, Keisala J, Isola J, Parnes JR, Leon F, Mäki M.
    Lancet Gastroenterol Hepatol; 2019 Dec 20; 4(12):948-959. PubMed ID: 31494096
    [Abstract] [Full Text] [Related]

  • 19. Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease.
    Freitag TL, Podojil JR, Pearson RM, Fokta FJ, Sahl C, Messing M, Andersson LC, Leskinen K, Saavalainen P, Hoover LI, Huang K, Phippard D, Maleki S, King NJC, Shea LD, Miller SD, Meri SK, Getts DR.
    Gastroenterology; 2020 May 20; 158(6):1667-1681.e12. PubMed ID: 32032584
    [Abstract] [Full Text] [Related]

  • 20. On the immune response to barley in celiac disease: Biased and public T-cell receptor usage to a barley unique and immunodominant gluten epitope.
    Dahal-Koirala S, Neumann RS, Jahnsen J, Lundin KEA, Sollid LM.
    Eur J Immunol; 2020 Feb 20; 50(2):256-269. PubMed ID: 31628754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.